Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Amyloidosis × pomalidomide × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 15 Recurrence 3 Neoplasms, Plasma Cell 2 Renal Insufficiency 1 Paraproteinemias 1 Neoplasms by Histologic Type 1 Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1 Hypoxia 1 High Grade Squamous Intra-epithelial Lesion (HSIL) 1 Hematologic Diseases 1 Disease Progression 1 Blood Protein Disorders 1 Amyloidosis 1

Interventions

Dexamethasone 2 pomalidomide 1 isatuximab 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Lisaftoclax 1 GTP Cyclohydrolase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡